Paid Clinical Trials in Mountain View, CA
As of June 2026, 42 paid clinical trials are recruiting in Mountain View, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mountain View offers studies at sites including Palo Alto Medical Foundation-Camino Division for conditions such as Neovascular Age-Related Macular Degeneration (nAMD), Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, AMD. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mountain View
Trials by drug in Mountain View
Filter results
42 clinical trials
↓ Download CSVStudying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan
Generative AI Plan for Care Lab Study
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
In Vivo Cross-Modal Imaging of Skin
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Artemis Sleep Countermeasures
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
STRIVE Post-Market Registry Study
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Extension Study for the Port Delivery System With Ranibizumab (Portal)
About research studies in Mountain View
Mountain View has approximately 42 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Mountain View
Researchers run research studies in Mountain View, CA at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Palo Alto Medical Foundation-Camino Division | Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 17 |
| Palo Alto Medical Foundation-Gynecologic Oncology | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 13 |
| Northern California Retina Vitreous Associates Medical Group Inc | AMD, Diabetic Retinopathy, DR, Gene Therapy | 2 |
| Northern California Retina Vitreous Associates Medical Group, Inc. | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 2 |
| Silicon Valley Gastroenterology | Healthy Subjects, Small Intestinal Bacterial Overgrowth | 2 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| El Camino Health | Benign Prostatic Hyperplasia, Overactive Bladder, Prostate Cancer | 1 |
| El Camino Hospital | Mitral Valve Regurgitation | 1 |
| El Camino, Taft Center for Clinical Research | Emphysema | 1 |
| Enspectra Health | Skin | 1 |
| Google LLC | Primary Health Care | 1 |
| Mountain View, California | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
| N CA Retina Vitreous Assoc | Neovascular Age-Related Macular Degeneration | 1 |
| NASA Ames Research Center | Fatigue | 1 |
| Northern California Retina Vitreous Associates | Neovascular Age-Related Macular Degeneration (nAMD) | 1 |
| Northern California Retina Vitreous Associates - Mountain View | Neovascular Age-related Macular Degeneration | 1 |
| Northern California Retina Vitreous Associates | Diabetic Retinopathy | 1 |
| Northern California Retina Vitreous Associates Medical Group | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Northern California Retina Vitreous Associates Medical Group INC. | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| Packard at El Camino Hospital | Gastroenteritis, Pneumonia, Soft Tissue Infections | 1 |
| Palo Alto Medical Foundation | Early Breast Cancer | 1 |
| Retina Vitreous Associates, Northern California Retina Vitreous Assoc Medical Group, Inc. | Epiretinal Membrane | 1 |
Active & Upcoming Studies in Mountain View (2026)
Recruiting trials in Mountain View grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · Phase 3 · NRG Oncology
Eye & vision (9 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Common conditions studied in Mountain View
- Neovascular Age-Related Macular Degeneration (nAMD) (2 active studies). Recruiting Neovascular Age-Related Macular Degeneration (nAMD) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage III Pancreatic Cancer AJCC v8 (2 active studies). Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes.
- Stage IV Pancreatic Cancer AJCC v8 (2 active studies). Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes.
- AMD (1 active study). Recruiting AMD studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Esophageal Adenocarcinoma (1 active study). Recruiting Advanced Esophageal Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Extrapulmonary Neuroendocrine Carcinoma (1 active study). Recruiting Advanced Extrapulmonary Neuroendocrine Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Mountain View
- NRG Oncology
- National Cancer Institute (NCI)
- AbbVie
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Mountain View. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Mountain View
Hipa.ai aggregates every recruiting study in Mountain View from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Mountain View?
There are approximately 42 recruiting clinical trials in Mountain View, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mountain View pay participants?
Most recruiting trials in Mountain View compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mountain View?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mountain View?
The most common conditions under active study in Mountain View include Neovascular Age-Related Macular Degeneration (nAMD) (2), Stage III Pancreatic Cancer AJCC v8 (2), Stage IV Pancreatic Cancer AJCC v8 (2), AMD (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mountain View?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mountain View on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mountain View?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mountain View?
Recruiting research sites in Mountain View include Palo Alto Medical Foundation-Camino Division, Palo Alto Medical Foundation-Gynecologic Oncology, Northern California Retina Vitreous Associates Medical Group Inc, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mountain View right now?
The largest active categories in Mountain View are Cancer & tumors (21), Eye & vision (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.